Chanatol Oral Solution

Kraj: Irlandia

Język: angielski

Źródło: HPRA (Health Products Regulatory Authority)

Składnik aktywny:

Cobalt sulphate heptahydrate; Propylene glycol

Dostępny od:

Chanelle Pharmaceuticals Manufacturing Limited

Kod ATC:

QA16QA

INN (International Nazwa):

Cobalt sulphate heptahydrate; Propylene glycol

Dawkowanie:

0.099, 99 percent weight/volume

Forma farmaceutyczna:

Oral solution

Typ recepty:

LR: Licensed Retailer as defined in national legislation

Grupa terapeutyczna:

Cattle, Goats, Sheep

Dziedzina terapeutyczna:

Drugs for prevention and/or treatment of acetonemia

Wskazania:

Vitamins and minerals

Status autoryzacji:

Authorised

Data autoryzacji:

1991-10-01

Charakterystyka produktu

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Chanatol Oral Solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Oral solution.
A clear, light pink coloured solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, sheep and goats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of acetonaemia in cattle and pregnancy toxaemia in
sheep and goats.
4.3 CONTRAINDICATIONS
Do not use in animals known to be hypersensitive to the active
substances.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None known.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
Wash splashes from the skin.
Each ml contains:
Active substances
Cobalt sulphate heptahydrate
0.099 % w/v
Propylene glycol
to 100
% w/v
For a full list of excipients, see section 6.1
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_3_
_/_
_0_
_1_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_6_
_8_
_2_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known at the correct dosage.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
The product may be used safely in pregnant and lactating animals.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For oral administration only.
Shake well before use.
Cat